VENLAFAXINE HYDROCHLORIDE
- Product NDC
- 10135-825
- 11-digit product format
- 101350825
- Labeler code
- 10135
- Product ID
- 10135-825_3d59e057-318b-f098-e063-6394a90a25be
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- VENLAFAXINE HYDROCHLORIDE
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Marlex Pharmaceuticals, Inc.
- Application
- ANDA201272
- Marketing category
- ANDA
- Marketing start
- 2025-08-01
- Substance
- VENLAFAXINE HYDROCHLORIDE
- Active strength
- 37.5 mg/1
- Pharmacologic classes
- Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| 7D7RX5A8MO | VENLAFAXINE HYDROCHLORIDE | 99300-78-4 | VENLAFAXINE HYDROCHLORIDE |
Packages
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 10135-825-10 | 10135082510 | 1000 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (10135-825-10) | 2025-08-01 | No | No | Historical |
| 10135-825-30 | 10135082530 | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (10135-825-30) | 2025-08-01 | No | No | Historical |
| 10135-825-75 | 10135082575 | 15 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (10135-825-75) | 2025-08-01 | No | No | Historical |
| 10135-825-90 | 10135082590 | 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (10135-825-90) | 2025-08-01 | No | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| VENLAFAXINE HYDROCHLORIDE | Marlex Pharmaceuticals, Inc. | 2025-08-01 | HUMAN PRESCRIPTION DRUG LABEL | 2 |